RWD Platform Value OneMedNet offers first-party, regulatory-grade RWD with multimodal data including imaging, yielding rapid cohort feasibility, data validation, and delivery. This positions them as a strategic partner for AI model development and regulatory submissions, suggesting sales opportunities with AI drug development teams and CROs seeking high-quality de-identified data.

Imaging Capabilities The iRWD platform uniquely integrates medical imaging with clinical data, enabling imaging-centric cohorts. This appeals to AI-driven imaging/diagnostic teams, radiology decision-support vendors, and pharma/biotech programs requiring imaging modalities for model training and validation.

Expanded Commercial Reach Recent multi-year resale agreement and partnerships indicate growing demand and scalable go-to-market potential. Target opportunities include enterprise pharma customers and AI developers looking for long-term data supply and strategic collaborations to accelerate model development.

Fast Delivery Timeline Customer announcements highlight rapid feasibility-to-delivery cycles (feasibility minutes, validation within a week, contract in weeks). Use this to position OneMedNet for time-sensitive studies, real-time analytics partnerships, and expedited regulatory-readiness data packages.

Financial Momentum Reported bookings growth and revenue scale, plus funding backing, signal financial health and market validation. This can be leveraged to engage larger enterprise clients and reassure procurement teams about reliability, scalability, and continued data quality enhancements.